Public Employees Retirement System of Ohio Purchases Shares of 30,490 Henry Schein, Inc. $HSIC

Public Employees Retirement System of Ohio acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 30,490 shares of the company’s stock, valued at approximately $2,547,000.

A number of other institutional investors also recently made changes to their positions in HSIC. CYBER HORNET ETFs LLC acquired a new position in shares of Henry Schein in the second quarter valued at approximately $25,000. MUFG Securities EMEA plc acquired a new stake in Henry Schein during the 2nd quarter worth approximately $27,000. Federated Hermes Inc. bought a new stake in Henry Schein in the 4th quarter valued at $32,000. Los Angeles Capital Management LLC acquired a new position in Henry Schein in the 4th quarter valued at $37,000. Finally, Trust Co. of Vermont acquired a new position in Henry Schein in the 2nd quarter valued at $42,000. Institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on HSIC shares. UBS Group set a $94.00 target price on Henry Schein and gave the stock a “neutral” rating in a report on Wednesday, August 5th. Wall Street Zen upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Monday, August 17th. Barrington Research set a $104.00 price target on shares of Henry Schein in a research report on Wednesday, August 5th. Barclays reissued an “overweight” rating and issued a $100.00 price objective (up from $86.00) on shares of Henry Schein in a report on Thursday, August 6th. Finally, Citigroup restated a “buy” rating and set a $112.00 target price (up from $100.00) on shares of Henry Schein in a research report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $92.93.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $89.81 on Friday. Henry Schein, Inc. has a 1 year low of $61.94 and a 1 year high of $92.18. The stock has a market capitalization of $10.01 billion, a price-to-earnings ratio of 26.18, a price-to-earnings-growth ratio of 1.71 and a beta of 0.81. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.73. The company’s 50 day simple moving average is $87.47 and its 200 day simple moving average is $80.35.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.03. The firm had revenue of $3.46 billion during the quarter, compared to analysts’ expectations of $3.37 billion. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.10 earnings per share. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. As a group, research analysts predict that Henry Schein, Inc. will post 5.36 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.